{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:27:12Z","timestamp":1772706432049,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejim.2020.10.015","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T16:59:50Z","timestamp":1602867590000},"page":"21-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Does hydroxychloroquine reduce mortality for COVID-19?"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8967-0400","authenticated-orcid":false,"given":"Silvano","family":"GALLUS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"CLAVENNA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"LUGO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2020.10.015_bib0001","article-title":"Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: findings from the observational multicentre Italian CORIST study","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2020.10.015_bib0002","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamacardio.2020.1782","article-title":"Hydroxychloroquine, coronavirus disease 2019, and QT prolongation","volume":"5","author":"Bonow","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"13","key":"10.1016\/j.ejim.2020.10.015_bib0003","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jama.2020.16253","article-title":"Emergency use authorizations during the COVID-19 pandemic: lessons from hydroxychloroquine for vaccine authorization and approval","volume":"324","author":"Thomson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2020.10.015_bib0004","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2019-9-1","article-title":"Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues","volume":"8","author":"Shukla","year":"2019","journal-title":"Drugs Context"},{"key":"10.1016\/j.ejim.2020.10.015_bib0005","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fmed.2020.00482","article-title":"Efficacy and safety of anti-malarial drugs (chloroquine and hydroxy-chloroquine) in treatment of COVID-19 infection: a systematic review and meta-analysis","volume":"7","author":"Das","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.ejim.2020.10.015_bib0006","unstructured":"WHO. WHO discontinues hydroxychloroquine and lopinavir\/ritonavir treatment arms for COVID-19. 2020 Jul 4. Available online at: https:\/\/www.who.int\/news-room\/detail\/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19. 2020."},{"key":"10.1016\/j.ejim.2020.10.015_bib0007","article-title":"Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials","author":"Axfors","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.ejim.2020.10.015_bib0008","article-title":"Hydroxychloroquine in COVID-19: an updated systematic review and meta-analysis","author":"Chacko","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.ejim.2020.10.015_bib0009","doi-asserted-by":"crossref","first-page":"287","DOI":"10.7326\/M20-2496","article-title":"Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review","volume":"173","author":"Hernandez","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2020.10.015_bib0010","article-title":"Update alert 2: hydroxychloroquine or chloroquine for the treatment or prophylaxis of COVID-19","author":"Hernandez","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2020.10.015_bib0011","article-title":"Effect of hydroxychloroquine in hospitalized patients with COVID-19: preliminary results from a multi-centre, randomized, controlled trial","author":"Horby","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.ejim.2020.10.015_bib0012","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19","volume":"383","author":"Boulware","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2020.10.015_bib0013","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.120.048238","article-title":"Cardiovascular toxicities associated with hydroxychloroquine and azithromycin: an analysis of the world health organization pharmacovigilance database","volume":"142","author":"Nguyen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2020.10.015_bib0014","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamacardio.2020.1787","article-title":"Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit","volume":"5","author":"Bessiere","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejim.2020.10.015_bib0015","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamacardio.2020.1834","article-title":"Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)","volume":"5","author":"Mercuro","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejim.2020.10.015_bib0016","article-title":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report","author":"Horby","year":"2020","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ejim.2020.10.015_bib0017","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520303927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520303927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:32:34Z","timestamp":1760607154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620520303927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":17,"alternative-id":["S0953620520303927"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2020.10.015","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does hydroxychloroquine reduce mortality for COVID-19?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2020.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}